US Broker Ratings

Humacyte, Inc. (HUMA) Stock Analysis: Exploring the 770% Potential Upside in Revolutionary Biotechnology

Humacyte, Inc. (NASDAQ: HUMA), a trailblazer in the biotechnology sector, is making waves with its innovative approach to bioengineered human tissues. As the company pioneers advanced therapeutic solutions, it presents..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Exploring a Promising 148.86% Upside in Biotech

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical firm, is currently catching the eye of investors with a compelling potential upside of 148.86%, according to recent analyst ratings. Specializing in..

Maze Therapeutics, Inc. (MAZE): Investor Outlook on Strong Buy Ratings and 12.50% Upside Potential

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company, has been making waves in the biotechnology sector with its innovative approach to developing small molecule precision medicines targeting renal, cardiovascular,..

PureTech Health plc (PRTC) Stock Analysis: Unpacking the Remarkable 542.70% Revenue Growth

For investors with an eye on the biotechnology sector, PureTech Health plc (NASDAQ: PRTC) presents a compelling case with its exceptional revenue growth metrics and diverse pipeline of innovative therapies...

Autolus Therapeutics plc (AUTL) Stock Analysis: A Biotech Gem with 606% Potential Upside

Autolus Therapeutics plc (NASDAQ: AUTL), a UK-based clinical-stage biopharmaceutical company, is grabbing attention in the healthcare sector with its promising pipeline of T cell therapies targeting cancer and autoimmune diseases...

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a 129% Potential Upside Amidst Promising Revenue Growth

For investors seeking opportunities in the healthcare sector, Organogenesis Holdings Inc. (NASDAQ: ORGO) presents an intriguing proposition. With its focus on regenerative medicine, the company is making strides in the..

Kamada Ltd. (KMDA) Stock Analysis: Exploring a 62% Potential Upside in Healthcare

Kamada Ltd. (NASDAQ: KMDA), a specialty and generic drug manufacturer headquartered in Israel, is attracting significant attention from investors. With a focus on plasma-derived protein therapeutics, Kamada’s diverse product portfolio..

Prothena Corporation plc (PRTA) Stock Analysis: 143.51% Potential Upside with Cutting-Edge Biotechnology Innovations

Prothena Corporation plc (NASDAQ: PRTA), a Dublin-based biotechnology company, is making waves in the healthcare sector with its promising pipeline of novel therapies aimed at tackling diseases caused by protein..

Weave Communications, Inc. (WEAV) Stock Analysis: 71% Potential Upside with Strong Buy Ratings

For investors seeking opportunities in the healthcare technology sector, Weave Communications, Inc. (WEAV) presents a compelling case. Specializing in health information services, Weave Communications offers a diverse suite of products..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 92% Potential Upside for Investors

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, is renowned for its innovative contributions to medical technology. Specializing in medical instruments and supplies, the company is carving..

Cel-Sci Corporation (CVM) Investor Outlook: Analyzing the 767% Potential Upside in Biotech Innovation

In the fast-evolving world of biotechnology, Cel-Sci Corporation (CVM) stands as an intriguing prospect for investors. With a focus on harnessing the power of the immune system to combat cancer..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Exploring a 59% Potential Upside in the Diagnostics Space

For investors seeking opportunities in the healthcare sector, Myriad Genetics, Inc. (NASDAQ: MYGN) presents a compelling case. This US-based molecular diagnostics company, with a market cap of approximately $475.39 million,..

Celcuity Inc. (CELC) Stock Analysis: Exploring a 5.96% Potential Upside in the Biotechnology Sector

Celcuity Inc. (NASDAQ: CELC), a prominent player in the biotechnology sector, is drawing investor attention with its promising drug development initiatives and a notable potential upside of 5.96%, as indicated..

Butterfly Network, Inc. (BFLY): Investor Outlook on a 56.73% Potential Upside

Butterfly Network, Inc. (BFLY), a pioneer in the healthcare sector, is making waves with its innovative medical devices, particularly in the ultrasound imaging domain. Known for its cutting-edge Butterfly iQ+..

CeriBell, Inc. (CBLL) Stock Analysis: 45.52% Potential Upside with Strong Buy Ratings in Medical Devices Sector

CeriBell, Inc. (CBLL), a U.S.-based medical technology company, is making waves in the healthcare sector with its innovative solutions for the diagnosis and management of serious neurological conditions. Focused primarily..

AtaiBeckley Inc. (ATAI): Biotech Stock with a Staggering 265% Potential Upside and Strong Buy Ratings

AtaiBeckley Inc. (ATAI), a dynamic player in the biotechnology sector, is capturing investor attention with its substantial growth potential and an impressive 265.24% potential upside, according to analyst ratings. As..

STAAR Surgical Company (STAA) Stock Analysis: Exploring the 38.40% Potential Upside

STAAR Surgical Company (NASDAQ: STAA), a key player in the medical instruments and supplies industry, has been generating buzz among healthcare investors for its innovative ocular products. Known for its..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a 247% Potential Upside in Biotech Innovation

Tectonic Therapeutic, Inc. (NASDAQ: TECX) stands out in the biotechnology sector with its innovative approach to developing GPCR-targeted biologic medicines. Despite a current price of $22.86 and a recent slight..

SIGA Technologies Inc. (SIGA) Stock Analysis: Exploring the Healthcare Innovator’s 39.94% ROE and Strategic Positioning

SIGA Technologies Inc. (NASDAQ: SIGA), a prominent player in the healthcare sector, stands out as a commercial-stage pharmaceutical company with a focus on the health security market. Headquartered in New..

Bioventus Inc. (BVS) Stock Analysis: An 82.70% Potential Upside Attracts Bullish Investor Sentiment

Bioventus Inc. (BVS), a key player in the healthcare sector focusing on medical devices, is capturing attention with an exceptional potential upside of 82.70%. This Durham, North Carolina-based company, founded..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds